Zobrazeno 1 - 10
of 183
pro vyhledávání: ''
Publikováno v:
Future Oncology
Introduction: Since breast imaging requires very close contact with patients, a protocol is needed to perform safe daily screening activities during the COVID-19 pandemic. Materials and methods: Patients were triaged and separated into three differen
Autor:
Arjun Sahgal, Umberto Ricardi, Hanbo Chen, Matthew Foote, Tithi Biswas, Kristin J. Redmond, Roi Dagan, Xuguang Chen, Darby Erler, Alexander V. Louie, Serena Badellino, Ian Poon
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6189-6198 (2021)
Cancer Medicine
Cancer Medicine
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods An international database of patients with OMD treated wi
Autor:
GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN, GEORGE NASIOULAS
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present data that demonstrate the different levels of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17928cee2350acf8044f319ac3d2bec4
https://europepmc.org/articles/PMC8717958/
https://europepmc.org/articles/PMC8717958/
Autor:
Felicia Casanova, Hector Arreola-Ornelas, Alessandra Durstine, Felicia Marie Knaul, Svetlana V. Doubova, Gabriela Sophia Pages, María Cecilia Gonzalez Robledo
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC Cancer
Background Qualitative research on cancer patients’ survivor-identity and lived experiences in low- and middle-income countries is scarce. Our study aimed at exploring the concept and experience of survivorship for Mexicans living with breast, cerv
Autor:
Thomas Kallemose, Lars Smith-Hansen, Maria Rasmussen, Lars Joachim Lindberg, Christina Therkildsen, Mef Nilbert
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Therkildsen, C, Rasmussen, M, Smith-Hansen, L, Kallemose, T, Lindberg, L J & Nilbert, M 2020, ' Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort ', BMC Cancer, vol. 20, no. 1, 345 . https://doi.org/10.1186/s12885-020-06859-5
BMC Cancer
Therkildsen, C, Rasmussen, M, Smith-Hansen, L, Kallemose, T, Lindberg, L J & Nilbert, M 2020, ' Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort ', BMC Cancer, vol. 20, no. 1, 345 . https://doi.org/10.1186/s12885-020-06859-5
BMC Cancer
Background Familial colorectal cancer type X (FCCTX) is a phenotypically defined subset of hereditary colorectal cancer with unknown and potentially heterogeneous genetic aetiology. FCCTX has been characterized as a colorectal cancer-specific syndrom
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background Cancer survivors and their caregivers may have various unmet needs that are medically difficult to solve. Previous studies have suggested the relations between individuals’ backgrounds and their unmet needs. We conducted a large-scale an
Autor:
Raymond Javan Chan, Louisa G. Gordon, David C. Whiteman, Astrid J. Rodriguez-Acevedo, Nirmala Pandeya, Catherine M. Olsen
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Background Patient medical out-of-pocket expenses are thought to be rising worldwide yet data describing trends over time is scant. We evaluated trends of out-of-pocket expenses for patients in Australia with one of five major cancers in the first-ye
Autor:
Kayo Nakata, Toshitaka Morishima, Keisuke Matsubayashi, Isao Miyashiro, Koji Kawakami, Akira Sato
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Cancer
BMC Cancer
Background Cancer survivors are frequently excluded from clinical research, resulting in their omission from the development of many cancer treatment strategies. Quantifying the prevalence of prior cancer in newly diagnosed cancer patients can inform
Autor:
Sabine Siesling, R.P.W.F. Wijn, Johanna Mattson, Anke Wind, W.H. van Harten, Jana Halámková, R.R.J.P. van Eekeren, E.D. Hartman
Publikováno v:
BMC Cancer
BMC cancer, 21(1):231. BioMed Central
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC cancer, 21(1):231. BioMed Central
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Background Taking patient centeredness into account is important in healthcare. The European Cancer Consumer Quality Index (ECCQI) is a validated tool for international benchmarking of patient experiences and satisfaction. This study aimed to further
Autor:
Ourania Katopodi, George Nasioulas, Stavroula Kampouri, Georgia Pepe, Rodoniki Iosifidou, Dan Tudor Eniu, Eirini Papadopoulou, Anna Koumarianou, Christos Markopoulos, Mehmet Tekinel, Serban Negru, Ioannis Xanthakis, V. Venizelos, Grigorios Xepapadakis, Sualp Tansan, Vahit Ozmen, Konstantinos Papazisis, Suayib Yalcin, Georgios N. Tsaousis, Nikolaos Diamantopoulos, E Banu, Theofanis Floros, Dana Lucia Stanculeanu, Konstantinos Agiannitopoulos, A Ungureanu, Angela Apessos
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
BMC Cancer
BMC Cancer
Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer